VCEL News and Press, Vericel Corporation From 06/14/21

At the conclusion of the 2021 Russell indexes annual reconstitution, following notable healthcare stocks will join the Russell Microcap Index, effective June 28 after the U.S. market opens.Asensus Surgical (ASXC), Organovo Holdings (ONVO), Senseonics Holdings (SENS), Clovis Onc...

CAMBRIDGE, Mass., June 09, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company overview at the Goldman Sachs 4...

CAMBRIDGE, Mass., June 02, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced the appointment of Lisa Wright to its Board of Directors, effective immediately. Ms. Wright will serve ...

When a successful corporate transformation occurs, the stock price usually increases substantially. After a name change, Vericel is now banking huge profits on its regenerative medicines (Maci, Epicel, and NexoBrid). I believe the upcoming PDUFA for NexoBrid will deliver positive ...

CAMBRIDGE, Mass., May 13, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced therapies for the sports medicine and severe burn care markets, today announced that Nick Colangelo, President and CEO, will present the latest company overview at the Canaccord Genuit...

Image source: The Motley Fool. Vericel (NASDAQ: VCEL) Q1 2021 Earnings Call May 05, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Vericel (VCEL) Q1 2021 Earnings Call Transcript

Vericel Corporation (VCEL) Q1 2021 Earnings Conference Call May 05, 2021 08:30 AM ET Company Participants Eric Burns - Head of Financial Planning & Analysis & Investors Relations Nick Colangelo - President & Chief Executive Officer Joe Mara - Chief Financial Officer Conference Cal...

The following slide deck was published by Vericel Corporation in conjunction with their 2021 Q1 earnings call. For further details see: Vericel Corporation 2021 Q1 - Results - Earnings Call Presentation

Vericel (VCEL): Q1 GAAP EPS of -$0.07 misses by $0.03.Revenue of $34.57M (+29.6% Y/Y) beats by $2.53M.Gross margin of 66%, compared to 63% in the first quarter of 2020.Non-GAAP adjusted EBITDA of $4.6 million, or 13% of net revenue, compared to adjusted EBITDA loss of $0.7 million in the firs...

First Quarter Total Net Revenue Increased 30% to $34.6 Million Full-Year 2021 Revenue Guidance Raised to $165-$168 Million Conference Call Today at 8:30am Eastern Time CAMBRIDGE, Mass., May 05, 2021 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in...